Sponsor:
National Institutes of Health
UI Contact:
Updated Date:
Mar 12, 2024
The National Institutes of Health, through its NIH Guide, has recently published the following funding-related notices and funding opportunities:
Policy Notices
- NIH Operates Under a Continuing Resolution
(NOT-OD-24-073)
National Institutes of Health
General Notices
- Notice of Question and Answer "Office Hours" with NIH Staff for Intervention Research to Improve Native American Health (IRINAH): PAR-23-298, PAR-23-285, PAR-23-299
(NOT-DA-24-015)
National Institute on Drug Abuse
- Notice Announcing the NIH Common Fund Data Ecosystem (CFDE) Cloud Workspace Implementation Center (OT2)
(NOT-RM-24-005)
Office of Strategic Coordination (Common Fund)
Notice of Changes to Funding Opportunities
- Notice of Participation of the National Institute on Aging in NOT-OD-24-044
(NOT-AG-24-003)
National Institute on Aging
- Notice of Correction to Key Dates Listed in PAR-24-091 and PAR-24-092 - Multidisciplinary Studies of HIV/AIDS and Aging (R01 & R21 Clinical Trial Optional)
(NOT-AG-24-008)
National Institute on Aging
- Notice of Change to Extend Last Receipt Date and the Expiration Date for PAR-21-185, "Mentoring Networks to Enhance Diversity in NIDCD's Extramural Research Workforce (R25 Clinical Trial Not Allowed)"
(NOT-DC-24-022)
National Institute on Deafness and Other Communication Disorders
- Notice of Change to Extend Last Receipt Date and the Expiration Date for PAR-21-186, "Enhancing NIDCD's Extramural Workforce Diversity through Research Experiences (R25 Clinical Trial Not Allowed)"
(NOT-DC-24-023)
National Institute on Deafness and Other Communication Disorders
- Notice of Change to Key Dates for PAS-23-086 - Small R01s for Clinical Trials Targeting Diseases within the Mission of NIDDK (R01 Clinical Trial Required)
(NOT-DK-24-016)
National Institute of Diabetes and Digestive and Kidney Diseases
- Notice of Extension of the Expiration Date for PAR-21-115 "Natural History of Disorders Screenable in the Newborn Period (R01 Clinical Trial Optional)"
(NOT-HD-24-001)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Notice of NHLBI Participation in PA-24-141 "NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)"
(NOT-HL-24-006)
National Heart, Lung, and Blood Institute
- Notice of Change to Key Dates for PAR-22-072, "Measures and Methods to Advance Research on Minority Health and Health Disparities-Related Constructs (R01 Clinical Trial Not Allowed)"
(NOT-MD-24-010)
National Institute on Minority Health and Health Disparities
- Notice of Participation of NIMH in PAR-23-302, "Developing novel theory and methods for understanding the genetic architecture of complex human traits (R01 Clinical Trial Not Allowed)"
(NOT-MH-24-200)
National Institute of Mental Health
- Notice of Clarification of NIMH Specific Areas of Research Interest in PAR-22-181 Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)
(NOT-MH-24-375)
National Institute of Mental Health
- Notice of Participation of the National Institute of Nursing Research (NINR) in NOT-OD-24-038, "Notice of Special Interest: Health Influences of Gender as a Social and Structural Variable"
(NOT-NR-24-007)
National Institute of Nursing Research
- Notice of Change: Extension of PAR-21-032: NINDS Ruth L. Kirschstein National Research Service Award (NRSA) for Training of Postdoctoral Fellows (F32 Clinical Trial Not Allowed)
(NOT-NS-24-069)
National Institute of Neurological Disorders and Stroke
- Notice of Correction to Application Due Dates for PAR-24-151 "Translational Neural Devices (R61/R33 - Clinical Trial Optional)"
(NOT-NS-24-072)
National Institute of Neurological Disorders and Stroke
- Notice of Extension of the Expiration Date for PAR-21-167 "Development of Animal Models and Related Biological Materials for Research (R21 Clinical Trial Not Allowed)
(NOT-OD-24-070)
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
- Notice of Change to Application Types Allowed in PAR-23-267 "Industrialization and Translation of Extracellular Vesicles for use in Regenerative Medicine (U43/U44 Clinical Trials Not Allowed)"
(NOT-TR-24-018)
National Center for Advancing Translational Sciences
- Notice of Change to Application Types Allowed in PAR-23-268 Industrialization and Translation of Extracellular Vesicles for use in Regenerative Medicine (UT1/UT2) Clinical Trial Not Allowed
(NOT-TR-24-019)
National Center for Advancing Translational Sciences
Notices of Intent to Publish
- Notice of Intent to Publish a Funding Opportunity Announcement for Implementing and Evaluating Patient-Centered Clinical Decision Support Strategies in Real-World Settings(U18)
(NOT-HS-24-009)
Agency for Healthcare Research and Quality
- Notice of Intent to Publish a Funding Opportunity Announcement for Materials to Enhance Training in Experimental Rigor (METER) (UE5 Clinical Trial Not Allowed)
(NOT-NS-24-053)
National Institute of Neurological Disorders and Stroke
Notices of Special Interest
- Notice of Special Interest (NOSI): U.S. Health in the International Perspective
(NOT-AG-24-004)
National Institute on Aging
- Notice of Special Interest (NOSI): Chemical Countermeasures Research Program (CCRP) Administrative Supplements to Promote the Development of Pediatric Research Models of Chemical Injury and Medical Countermeasures Discovery
(NOT-AI-24-022)
National Institute of Allergy and Infectious Diseases
National Eye Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute on Drug Abuse
National Institute of Environmental Health Sciences
National Institute of Neurological Disorders and Stroke
- Notice of Special Interest (NOSI): National Center for Complementary and Integrative Health (NCCIH) T32 Supplement Program to Promote Diversity in Health Research
(NOT-AT-24-034)
National Center for Complementary and Integrative Health
- Notice of Special Interest (NOSI): Interventions to Reduce Chronic Inflammation and Inflammation-Related Morbidity in People Living with HIV/AIDS
(NOT-AT-24-035)
National Center for Complementary and Integrative Health
National Institute on Aging
- Notice of Special Interest (NOSI): Epidemiologic Studies to Assess the Impact of Incretin Mimetics on New and Recurrent Cancer Risk
(NOT-CA-24-037)
National Cancer Institute
- Notice of Special Interest (NOSI): Saving Lives: Integrating Overdose Education and Naloxone Distribution (OEND) into HIV Prevention and Care Settings for People Who Use Addictive Substances
(NOT-DA-25-031)
National Institute on Drug Abuse
- Notice of Special Interest (NOSI): Training and Career Development in Dissemination and Implementation Science for Research in Communication Disorders
(NOT-DC-24-024)
National Institute on Deafness and Other Communication Disorders
Funding Opportunities
- NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)
(PA-24-141)
National Institutes of Health
National Center for Advancing Translational Sciences
National Center for Complementary and Integrative Health
National Cancer Institute
National Eye Institute
National Human Genome Research Institute
National Heart, Lung, and Blood Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Environmental Health Sciences
National Institute of General Medical Sciences
National Institute of Mental Health
National Institute on Minority Health and Health Disparities
National Institute of Neurological Disorders and Stroke
National Library of Medicine
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs - Medical Scientist Training Program (MSTP) (T32)
(PAR-24-128)
National Institute of General Medical Sciences - Limited Competition: Alcohol-associated Hepatitis Clinical Network Integrated Treatment Clinical Trials Clinical Centers (U01-Clinical Trial required)
(RFA-AA-24-004)
National Institute on Alcohol Abuse and Alcoholism - Limited Competition: Alcohol-associated Hepatitis Clinical Network Integrated Treatment Clinical Trials Data Coordinating Center (U24 - Clinical Trial Required)
(RFA-AA-24-005)
National Institute on Alcohol Abuse and Alcoholism - Model Continuums of Care Initiative (MCCI) to Advance Health Equity and End Health Disparities Among Women and Girls in Racial/Ethnic Minority and Other Underserved Communities (U34 Clinical Trials Required)
(RFA-AA-24-006)
National Institute on Alcohol Abuse and Alcoholism
National Institute on Minority Health and Health Disparities
National Institute of Nursing Research - Research Training in Aging for Medical Students (T35)
(RFA-AG-25-009)
National Institute on Aging - Leveraging Data at Scale to Understand Natural Product Impacts on Whole Person Health (R01 Clinical Trial Not Allowed)
(RFA-AT-24-008)
National Center for Complementary and Integrative Health
Office of Dietary Supplements - Cooperative Agreement to Support the World Trade Organization's (WTO) Standards and Trade Development Facility (STDF) (U01) Clinical Trials Not Allowed
(RFA-FD-24-016)
Food and Drug Administration - Use of Digital Health Technologies in Clinical Investigations to Support Drug and Biological Product Development (U01) Clinical Trials Optional
(RFA-FD-24-037)
Food and Drug Administration - Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparities (R43/R44 - Clinical Trial Optional)
(RFA-MD-24-006)
National Institute on Minority Health and Health Disparities
National Center for Advancing Translational Sciences
National Heart, Lung, and Blood Institute
National Institute on Aging
National Institute of Biomedical Imaging and Bioengineering
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Nursing Research - Technologies for Improving Minority Health and Eliminating Health Disparities (R41/R42- Clinical Trial Optional)
(RFA-MD-24-007)
National Institute on Minority Health and Health Disparities
National Center for Advancing Translational Sciences
National Institute of Biomedical Imaging and Bioengineering
National Institute of Dental and Craniofacial Research
National Institute of Nursing Research - Strategies to Improve Health Outcomes and Advance Health Equity in Rural Populations (R01 Clinical Trial Optional)
(RFA-NR-24-005)
National Institute of Nursing Research
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Mental Health
National Institute on Minority Health and Health Disparities
Office of Behavioral and Social Sciences Research
Office of Nutrition Research
Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at dsp@uiowa.edu(link sends e-mail) or 313-335-2123, or email Ann Ricketts(link sends e-mail) or Lynn Hudachek(link sends e-mail).